...
首页> 外文期刊>Tropical Medicine and International Health: TM and IH >Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa
【24h】

Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa

机译:南非约翰内斯堡孕妇在怀孕期间检测出HIV阳性的妇女分娩前后的随访损失

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: HIV-positive pregnant women are at heightened risk of becoming lost to follow-up (LTFU) from HIV care. We examined LTFU before and after delivery among pregnant women newly diagnosed with HIV. Methods: Observational cohort study of all pregnant women ≥18 years (N = 300) testing HIV positive for the first time at their first ANC visit between January and June 2010, at a primary healthcare clinic in Johannesburg, South Africa. Women (n = 27) whose delivery date could not be determined were excluded. Results: Median (IQR) gestation at HIV testing was 26 weeks (21-30). Ninety-eight per cent received AZT prophylaxis, usually started at the first ANC visit. Of 139 (51.3%) patients who were ART eligible, 66.9% (95% CI 58.8-74.3%) initiated ART prior to delivery; median (IQR) ART duration pre-delivery was 9.5 weeks (5.1-14.2). Among ART-eligible patients, 40.5% (32.3-49.0%) were cumulatively retained through 6 months on ART. Of those ART-ineligible patients at HIV testing, only 22.6% (95% CI 15.9-30.6%) completed CD4 staging and returned for a repeat CD4 test after delivery. LTFU (≥1 month late for last scheduled visit) before delivery was 20.5% (95% CI 16.0-25.6%) and, among those still in care, 47.9% (95% CI 41.2-54.6%) within 6 months after delivery. Overall, 57.5% (95% CI 51.6-63.3%) were lost between HIV testing and 6 months post-delivery. Conclusions: Our findings highlight the challenge of continuity of care among HIV-positive pregnant women attending antenatal services, particularly those ineligible for ART.
机译:目的:艾滋病毒阳性孕妇因接受艾滋病毒护理而无法跟进(LTFU)的风险更高。我们在刚被确诊为HIV的孕妇中检查了分娩前后的LTFU。方法:2010年1月至2010年6月在南非约翰内斯堡的一家初级保健诊所首次对ANC进行首次HIV阳性的所有≥18岁(N = 300)孕妇进行观察性队列研究。无法确定分娩日期的妇女(n = 27)被排除在外。结果:HIV检测的妊娠中位数(IQR)为26周(21-30)。 98%的患者接受了AZT预防,通常是在第一次ANC访视时开始。在139名(51.3%)符合抗逆转录病毒治疗资格的患者中,有66.9%(95%CI 58.8-74.3%)的患者在分娩前开始接受抗逆转录病毒治疗;分娩前中位(IQR)ART持续时间为9.5周(5.1-14.2)。在符合抗逆转录病毒治疗资格的患者中,在接受抗逆转录病毒治疗的6个月内累计保留了40.5%(32.3-49.0%)。在接受HIV检测的那些不符合ART资格的患者中,只有22.6%(95%CI 15.9-30.6%)完成了CD4分期并在分娩后返回进行了重复CD4测试。分娩前的LTFU(上次预定访诊时间晚于≥1个月)为20.5%(95%CI 16.0-25.6%),在仍处于护理状态的患者中,分娩后6个月内为47.9%(95%CI 41.2-54.6%)。总体而言,从HIV检测到分娩后6个月之间损失了57.5%(95%CI 51.6-63.3%)。结论:我们的研究结果突显了接受产前服务的HIV阳性孕妇,尤其是那些不适合接受抗逆转录病毒治疗的孕妇持续护理的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号